Literature DB >> 7092338

C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis.

M Gwyther, H Schwarz, A Howard, B M Ansell.   

Abstract

C-reactive protein (CRP) was found to be particularly high early in the course of those cases of juvenile chronic arthritis (JCA) with a systemic onset, the mean level being 12 mg/dl (120 mg/l). It was also raised in cases with a polyarticular onset, mean level 6 mg/dl, while in cases with a pauciarticular onset it was associated with only a modest increase up to 1.5 mg/dl (15 mg/l). At the onset of disease there was a good correlation with the erythrocyte sedimentation rate (ESR). Regression of systemic disease was associated with a steady fall in C-reactive protein, but those patients who developed amyloidosis within 5 years from onset had persistently high values until cytotoxic therapy was introduced. Patients who developed amyloidosis later tended to have high CRP levels in the months or even years before diagnosis. In a few patients with polyarthritis the CRP appeared to reflect severe disease more closely than their relatively low ESR.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092338      PMCID: PMC1000923          DOI: 10.1136/ard.41.3.259

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

3.  Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.

Authors:  L Walsh; P Davies; B McConkey
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

4.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

5.  C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; D Cawdell; M Ishii; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

6.  C-reactive protein and delayed hypersensitivity in juvenile rheumatoid arthritis.

Authors:  O J Mellbye; H M Høyeraal; S S Frøland
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

  6 in total
  5 in total

1.  Fever of unknown origin in childhood: difficulties in diagnosis.

Authors:  K Martin; E G Davies; J S Axford
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

2.  Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.

Authors:  Justin R Yu; Kieron S Leslie
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

3.  Amyloidosis in Whipple's arthritis.

Authors:  M Farr; C Morris; C A Hollywell; D L Scott; K W Walton; P A Bacon
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

4.  α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis.

Authors:  Ludwig Zeller; Pascal N Tyrrell; Stella Wang; Nadine Fischer; Johannes-Peter Haas; Boris Hügle
Journal:  Pediatr Rheumatol Online J       Date:  2022-08-13       Impact factor: 3.413

5.  Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients.

Authors:  Miao Feng; Min Kang; Feng He; Zonghui Xiao; Zhewei Liu; Hailan Yao; Jianxin Wu
Journal:  J Transl Med       Date:  2018-10-11       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.